What is the average price target for XEROX HOLDINGS CORP (XRX) stock?
10 analysts have analysed XRX and the average price target is 2.3 USD. This implies a price increase of 86.59% is expected in the next year compared to the current price of 1.23.
NASDAQ:XRX • US98421M1062
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XEROX HOLDINGS CORP (XRX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-30 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-08-18 | Citigroup | Reiterate | Neutral |
| 2024-10-30 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-10-30 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-10-21 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-08-14 | Loop Capital | Maintains | Hold -> Hold |
| 2024-06-28 | Citigroup | Initiate | Sell |
| 2024-04-24 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-01-26 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-10-25 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-10-25 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-07-26 | Credit Suisse | Maintains | Underperform -> Underperform |
| 2023-07-26 | Morgan Stanley | Reiterate | Underweight -> Underweight |
| 2023-04-26 | Morgan Stanley | Maintains | Underweight |
| 2022-10-26 | Citigroup | Maintains | Sell |
| 2022-10-18 | Credit Suisse | Maintains | Underperform |
| 2022-10-17 | Morgan Stanley | Maintains | Underweight |
| 2022-08-17 | Credit Suisse | Initiate | Underperform |
| 2022-07-27 | Morgan Stanley | Maintains | Underweight |
| 2022-07-14 | JP Morgan | Maintains | Underweight |
| 2022-04-22 | Morgan Stanley | Maintains | Underweight |
| 2022-04-22 | Citigroup | Maintains | Sell |
| 2021-09-23 | Morgan Stanley | Initiate | Underweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.886B -3.11% | 6.221B -9.66% | 7.022B 12.88% | 7.651B 8.96% | 7.563B -1.15% | 7.515B -0.63% | |
| EBITDA YoY % growth | 597M 23.86% | 433M -27.47% | 265M -38.80% | 579.48M 118.67% | 705.19M 21.69% | 770.17M 9.21% | |
| EBIT YoY % growth | 346M 63.21% | 159M -54.05% | -66M -141.51% | 420.32M 736.85% | 536.02M 27.53% | 519.69M -3.05% | |
| Operating Margin | 5.02% | 2.56% | -0.94% | 5.49% | 7.09% | 6.92% | |
| EPS YoY % growth | 1.82 66.97% | 0.96 -47.25% | -0.60 -162.50% | 0.47 177.55% | 1.17 151.05% | 1.06 -9.55% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -360.11% | -0.01 98.00% | 0.19 -4.39% | 0.56 662.90% | 0.04 114.63% | 0.28 2,309.94% | 0.30 58.45% | 0.48 -13.88% |
| Revenue Q2Q % growth | 1.764B 21.07% | 1.884B 19.54% | 1.953B -0.41% | 2.051B 1.13% | 1.766B 0.11% | 1.933B 2.60% | 1.854B -5.07% | 1.925B -6.14% |
| EBITDA Q2Q % growth | 69.161M 23.50% | 114.58M -22.05% | 161.4M 83.41% | 234.84M -37.38% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 32.304M 907.60% | 79.082M 163.61% | 118.04M 186.79% | 191.24M 334.64% | 85.85M 165.76% | 129.28M 63.48% | 133.32M 12.94% | 170.69M -10.75% |
All data in USD
10 analysts have analysed XRX and the average price target is 2.3 USD. This implies a price increase of 86.59% is expected in the next year compared to the current price of 1.23.
XEROX HOLDINGS CORP (XRX) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of XEROX HOLDINGS CORP (XRX) is -0.28 USD and the consensus revenue estimate is 1.76B USD.
The consensus rating for XEROX HOLDINGS CORP (XRX) is 46 / 100 . This indicates that analysts generally have a neutral outlook on the stock.